Cargando...
Advances in the treatment of relapsed/refractory chronic lymphocytic leukemia
Treatment of chronic lymphocytic leukemia (CLL) has advanced with the introduction of chemoimmunotherapy (CIT) agents that have improved the outcomes of frontline therapy. However, most treated patients will relapse and require subsequent therapy. This review focuses on recent advances in the treatm...
Guardado en:
| Publicado en: | Ann Hematol |
|---|---|
| Autores principales: | , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Springer Berlin Heidelberg
2017
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5486803/ https://ncbi.nlm.nih.gov/pubmed/28389687 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00277-017-2982-1 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|